Citigroup Inc Codexis, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Citigroup Inc holds 51,335 shares of CDXS stock, worth $262,835. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,335

Previous 15,886 223.15%

Holding current value

$262,835

Previous $49,000 222.45%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.62 - $3.71 $92,876 - $131,515	35,449 Added 223.15%	51,335 $158,000
Q2 2024 Aug 12, 2024	BUY	$2.65 - $3.92 $7,202 - $10,654	2,718 Added 20.64%	15,886 $49,000
Q1 2024 May 10, 2024	BUY	$2.59 - $4.65 $7,775 - $13,959	3,002 Added 29.53%	13,168 $45,000
Q4 2023 Feb 09, 2024	BUY	$1.54 - $3.37 $14,032 - $30,707	9,112 Added 864.52%	10,166 $31,000
Q3 2023 Nov 09, 2023	SELL	$1.5 - $3.75 $29,907 - $74,767	-19,938 Reduced 94.98%	1,054 $1,000
Q2 2023 Aug 10, 2023	SELL	$2.21 - $4.43 $2,797 - $5,608	-1,266 Reduced 5.69%	20,992 $58,000
Q1 2023 May 11, 2023	SELL	$3.81 - $6.76 $10,584 - $18,779	-2,778 Reduced 11.1%	22,258 $92,000
Q4 2022 Feb 09, 2023	BUY	$4.26 - $6.84 $33,786 - $54,248	7,931 Added 46.37%	25,036 $116,000
Q3 2022 Nov 10, 2022	BUY	$6.06 - $12.86 $1,781 - $3,780	294 Added 1.75%	17,105 $103,000
Q2 2022 Aug 10, 2022	SELL	$8.35 - $21.89 $19,764 - $51,813	-2,367 Reduced 12.34%	16,811 $175,000
Q1 2022 May 12, 2022	SELL	$16.97 - $31.93 $244,690 - $460,398	-14,419 Reduced 42.92%	19,178 $396,000
Q4 2021 Feb 10, 2022	SELL	$25.61 - $41.78 $395,623 - $645,417	-15,448 Reduced 31.5%	33,597 $1.05 Million
Q3 2021 Nov 10, 2021	BUY	$19.65 - $27.99 $963,734 - $1.37 Million	49,045 New	49,045 $1.14 Million

Others Institutions Holding CDXS

# of Institutions

125

Shares Held

59.9M

Call Options Held

25.9K

Put Options Held

20.1K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account